{
    "nctId": "NCT06144346",
    "briefTitle": "Metastases Directed Therapy for Oligometastatic Breast Cancer",
    "officialTitle": "Role of Metastases Directed Radiotherapy in Addition to Standard of Care Systemic Treatment in the Management of Extracranial Oligometastatic Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Breast Cancer, Metastatic Cancer, Metastatic Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "NA",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 150,
    "primaryOutcomeMeasure": "Progression Free Survival",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Female patients aged 18 to 70 years.\n* Pathological evidence of breast cancer, any grade, any T stage.\n* Radiological (at least) evidence of metastatic activity with maximum number of 5 extracranial lesions.\n* Performance status \u2264 2\n* No pre-existing conditions that may prohibit radiotherapy.\n\nExclusion Criteria:\n\n\u2022.Pregnant and lactating women.\n\n* Prior radiotherapy to affected site(s) in less than a year.\n* Active Connective tissue diseases (e.g Rheumatoid Arthritis).\n* Progression to widespread metastatic disease\n* Cases with brain metastasis",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}